Quantamental Technologies LLC Fate Therapeutics Inc Transaction History

Quantamental Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$17.78 - $42.39 $151,592 - $361,417	8,526 New	8,526 $211,000
Q1 2022 May 16, 2022	SELL	$29.67 - $60.28 $174,251 - $354,024	-5,873 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$47.84 - $64.34 $280,964 - $377,868	5,873 New	5,873 $344,000
Q4 2020 Feb 16, 2021	SELL	$38.09 - $100.95 $241,338 - $639,619	-6,336 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$30.41 - $40.5 $192,677 - $256,608	6,336 New	6,336 $253,000
Q4 2019 Feb 14, 2020	SELL	$13.39 - $20.73 $80,098 - $124,006	-5,982 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$15.47 - $22.5 $92,541 - $134,595	5,982 New	5,982 $93,000
Q2 2019 Aug 12, 2019	SELL	$15.61 - $20.44 $1,217 - $1,594	-78 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$13.15 - $18.71 $1,025 - $1,459	78 New	78 $1,000

167

101M

41.3K

15.9K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $82.5M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.